Patient profile of nonresponders to ustekinumab in moderate-to-severe psoriasis patients enrolled in the Corrona Psoriasis Registry

被引：0
|
作者：
van Voorhees, Abby S. [1 ]
Karki, Chitra [2 ]
Mason, Marc A. [2 ]
Harrold, Leslie R. [2 ]
Guo, Ning [2 ]
Guana, Adriana [3 ]
Tian, Haijun [3 ]
Herrra, Vivian [3 ]
Strober, Bruce E. [4 ]
机构：
[1] Eastern Virginia Med Sch, Norfolk, VA 23501 USA
[2] Corrona LLC, Waltham, MA USA
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Univ Connecticut, Storrs, CT USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2018年 / 79卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
6184
引用
收藏
页码：AB216 / AB216
页数：1
相关论文
共 50 条
  • [21] Long-term outcomes of ustekinumab in patients with moderate-to-severe psoriasis in a university hospital
    Ossorio-Garcia, Lidia
    Collantes-Rodriguez, Cristina
    Jimenez-Gallo, David
    Linares-Barrios, Mario
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB179 - AB179
  • [22] Ustekinumab demonstrates rapid onset of efficacy in the treatment of moderate-to-severe psoriasis
    Rich, P.
    Feldman, S.
    Vender, R.
    Ortonne, J. P.
    Rustin, M.
    Kunynetz, R.
    Yeilding, N.
    Fakharzadeh, S.
    Li, S.
    Prinz, J.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 18 - 18
  • [23] Ustekinumab in Real-Life Practice: Experience in 116 Patients with Moderate-To-Severe Psoriasis
    Raposo, Ines
    Bettencourt, Andreia
    Leite, Luiz
    Selores, Manuela
    Torres, Tiago
    [J]. ACTA MEDICA PORTUGUESA, 2019, 32 (03): : 214 - 218
  • [24] Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis using the CorEvitas Psoriasis Registry
    Strober, Bruce
    Ferris, Laura
    Duffin, Kristina Callis
    Janak, Jud C.
    Sima, Adam P.
    Eckmann, Thomas
    Patel, Manish
    Photowala, Huzefa
    Garg, Vishvas
    Armstrong, April
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (01) : 82 - 90
  • [25] The Effectiveness of Guselkumab by BMI Category Among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry
    April W. Armstrong
    Timothy Fitzgerald
    Robert R. McLean
    Amanda Teeple
    Jonathan P. Uy
    Mobolaji Olurinde
    Katelyn Rowland
    Lin Guo
    Ying Shan
    Kristina Callis Duffin
    [J]. Advances in Therapy, 2023, 40 : 2493 - 2508
  • [26] The Effectiveness of Guselkumab by BMI Category Among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry
    Armstrong, April W.
    Fitzgerald, Timothy
    McLean, Robert R.
    Teeple, Amanda
    Uy, Jonathan P.
    Olurinde, Mobolaji
    Rowland, Katelyn
    Guo, Lin
    Shan, Ying
    Callis Duffin, Kristina
    [J]. ADVANCES IN THERAPY, 2023, 40 (05) : 2493 - 2508
  • [27] Influenza vaccination rate among patients with moderate-to-severe psoriasis in the German National Psoriasis Registry PsoBest
    Radtke, M. A.
    Rustenbach, S. J.
    Reusch, M.
    Augustin, M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E160 - E161
  • [28] Treatment profile of patients with moderate-to-severe psoriasis included in the Turkish national registry PSR-TR
    Onsun, N.
    Baskan, E. B.
    Dizman, D.
    Ozkaya, D. B.
    Erkilic, A. C.
    Ozarmagan, G.
    Gurer, M. A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E268 - E268
  • [29] Ustekinumab for the treatment of moderate to severe psoriasis
    Gospodarevskaya, E.
    Picot, J.
    Cooper, K.
    Loveman, E.
    Takeda, A.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 61 - 66
  • [30] Patient choice of dosing frequency among moderate-to-severe plaque psoriasis patients with adalimumab, etanercept, and/or ustekinumab experience
    Carter, Chureen
    Farahi, Kamyar
    Johnson, Michael P.
    Olson, William
    Zhang, Mingliang
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB262 - AB262
12345